175 related articles for article (PubMed ID: 30859243)
1. Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection.
Darley DR; Carlos L; Hennig S; Liu Z; Day R; Glanville AR
Eur J Clin Pharmacol; 2019 Jul; 75(7):879-888. PubMed ID: 30859243
[TBL] [Abstract][Full Text] [Related]
2. Is There a Temporal Relationship Between Trough Whole Blood Tacrolimus Concentration and Acute Rejection in the First 14 Days After Kidney Transplantation?
Hu R; Barratt DT; Coller JK; Sallustio BC; Somogyi AA
Ther Drug Monit; 2019 Aug; 41(4):528-532. PubMed ID: 31259882
[TBL] [Abstract][Full Text] [Related]
3. Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: toward updated genotype-based dosage guidelines.
Elens L; Capron A; van Schaik RH; De Meyer M; De Pauw L; Eddour DC; Latinne D; Wallemacq P; Mourad M; Haufroid V
Ther Drug Monit; 2013 Oct; 35(5):608-16. PubMed ID: 24052064
[TBL] [Abstract][Full Text] [Related]
4. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
[TBL] [Abstract][Full Text] [Related]
5. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection.
Capron A; Lerut J; Verbaandert C; Mathys J; Ciccarelli O; Vanbinst R; Roggen F; De Reyck C; Lemaire J; Wallemacq PE
Ther Drug Monit; 2007 Jun; 29(3):340-8. PubMed ID: 17529892
[TBL] [Abstract][Full Text] [Related]
6. A Lack of Significant Effect of POR*28 Allelic Variant on Tacrolimus Exposure in Kidney Transplant Recipients.
Jannot AS; Vuillemin X; Etienne I; Buchler M; Hurault de Ligny B; Choukroun G; Colosio C; Thierry A; Vigneau C; Moulin B; Rerolle JP; Heng AE; Subra JF; Legendre C; Beaune P; Loriot MA; Thervet E; Pallet N
Ther Drug Monit; 2016 Apr; 38(2):223-9. PubMed ID: 26829596
[TBL] [Abstract][Full Text] [Related]
7. Intrapatient Variability in Tacrolimus Trough Levels Over 2 Years Affects Long-Term Allograft Outcomes of Kidney Transplantation.
Park Y; Lee H; Eum SH; Kim HD; Ko EJ; Yang CW; Chung BH
Front Immunol; 2021; 12():746013. PubMed ID: 34659243
[TBL] [Abstract][Full Text] [Related]
8. CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation.
Hu R; Barratt DT; Coller JK; Sallustio BC; Somogyi AA
Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):320-326. PubMed ID: 29603629
[TBL] [Abstract][Full Text] [Related]
9. Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure.
Shuker N; Cadogan M; van Gelder T; Roodnat JI; Kho MM; Weimar W; Hesselink DA
Ther Drug Monit; 2015 Apr; 37(2):262-9. PubMed ID: 25265255
[TBL] [Abstract][Full Text] [Related]
10. Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy.
García Sánchez MJ; Manzanares C; Santos-Buelga D; Blázquez A; Manzanares J; Urruzuno P; Medina E
Clin Pharmacokinet; 2001 Jan; 40(1):63-71. PubMed ID: 11236810
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus pharmacokinetics in lung transplantation: new strategies for monitoring.
Ragette R; Kamler M; Weinreich G; Teschler H; Jakob H
J Heart Lung Transplant; 2005 Sep; 24(9):1315-9. PubMed ID: 16143250
[TBL] [Abstract][Full Text] [Related]
12. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation.
Yang JW; Liao SS; Zhu LQ; Zhao Y; Zhang Y; Sun XY; Rao W; Qu W; Li WZ; Sun LY
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):75-83. PubMed ID: 25207550
[TBL] [Abstract][Full Text] [Related]
14. Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management.
Shuker N; van Gelder T; Hesselink DA
Transplant Rev (Orlando); 2015 Apr; 29(2):78-84. PubMed ID: 25687818
[TBL] [Abstract][Full Text] [Related]
15. Lessons from routine dose adjustment of tacrolimus in renal transplant patients based on global exposure.
Saint-Marcoux F; Woillard JB; Jurado C; Marquet P
Ther Drug Monit; 2013 Jun; 35(3):322-7. PubMed ID: 23666572
[TBL] [Abstract][Full Text] [Related]
16. Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase.
Aouam K; Kolsi A; Kerkeni E; Ben Fredj N; Chaabane A; Monastiri K; Boughattas N
Pharmacogenomics; 2015 Dec; 16(18):2045-54. PubMed ID: 26615671
[TBL] [Abstract][Full Text] [Related]
17. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of tacrolimus in early stage after heart transplantation.
Aidong W; Zhenjie C; Tong L; Lei Z; Yin W; Shanqi Z; Liping T
Transplant Proc; 2004 Oct; 36(8):2388-9. PubMed ID: 15561258
[TBL] [Abstract][Full Text] [Related]
19. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
Kuypers DR; Vanrenterghem Y
Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
[TBL] [Abstract][Full Text] [Related]
20. Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.
Niioka T; Satoh S; Kagaya H; Numakura K; Inoue T; Saito M; Narita S; Tsuchiya N; Habuchi T; Miura M
Transplantation; 2012 Nov; 94(10):1013-9. PubMed ID: 23073468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
